VaramirStart free · no cardSign in
AMLX as of Oct 31 · 22:47 ET
AMLXNasdaqPharmaceutical Preparations

Amylyx Pharmaceuticals, Inc. · Brief

Next report

4 days

Nov 5 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±15.8%
avg realized
±5.7%
Nov 7 '24±12.4%▲+5.14%×0.42
Mar 4 '25±14.7%▲+0.33%×0.02
May 8 '25±11.5%▼−5.95%×0.52
Aug 7 '25±13.6%▼−4.27%×0.31
Nov 6 '25±18.9%▼−5.89%×0.31
Q1 FY26±17.6%▼−7.78%×0.44
May 7 '26±11.9%▼−5.35%×0.45
Q2 FY26±25.6%▲+10.71%×0.42
quarterimplied−30%0+30%realized×
Q2 FY26±25.6%▲+10.71%×0.42
May '26±11.9%▼−5.35%×0.45
Q1 FY26±17.6%▼−7.78%×0.44
Nov '25±18.9%▼−5.89%×0.31
Aug '25±13.6%▼−4.27%×0.31
May '25±11.5%▼−5.95%×0.52
2 older reports
Mar '25±14.7%▲+0.33%×0.02
Nov '24±12.4%▲+5.14%×0.42
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2

207managers reporting a position in the latest quarterly filings13F · Jun 30 '26
+2.14%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 4

3tracked funds holding AMLXN-PORT · Aug 31 '26
0.05%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

AMLX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±12.1% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.